M

Seres Therapeutics
D

MCRB

9.24000
USD
0.23
(2.55%)
مغلق
حجم التداول
3,973
الربح لكل سهم
-8
العائد الربحي
-
P/E
14
حجم السوق
83,589,836
أصول ذات صلة المقالات

العنوان: Seres Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.